Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
43.3M
-
Shares change
-
+8.34M
-
Total reported value, excl. options
-
$1.77B
-
Value change
-
+$339M
-
Put/Call ratio
-
12.01
-
Number of buys
-
77
-
Number of sells
-
-41
-
Price
-
$40.80
Significant Holders of SOLENO THERAPEUTICS INC - Common Stock, par value $0.001 per share (SLNO) as of Q2 2024
138 filings reported holding SLNO - SOLENO THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q2 2024.
SOLENO THERAPEUTICS INC - Common Stock, par value $0.001 per share (SLNO) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.3M shares
of 50M outstanding shares and own 86.63% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (7.32M shares), Carlyle Group Inc. (4.07M shares), JANUS HENDERSON GROUP PLC (3.36M shares), PERCEPTIVE ADVISORS LLC (3.2M shares), Nantahala Capital Management, LLC (3.08M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.85M shares), Avoro Capital Advisors LLC (2.09M shares), BlackRock Inc. (1.86M shares), VANGUARD GROUP INC (1.5M shares), and COMMODORE CAPITAL LP (1.43M shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.